SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640334-19-000411
Filing Date
2019-03-21
Accepted
2019-03-21 14:39:14
Documents
4
Period of Report
2019-03-20
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_8k.htm 8-K 12383
2 EX-99.1 lxrp_ex991.htm EX-99.1 9353
3 lxrp_8kimg1.jpg GRAPHIC 3113
4 lxrp_8kimg2.jpg GRAPHIC 2950
  Complete submission text file 0001640334-19-000411.txt   31625
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-52138 | Film No.: 19696744
SIC: 1000 Metal Mining